Covered recipient · General Payments record
CARLY SCHNEIDER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,595.73
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $544.99 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $234.51 | 17 |
| DEXCOM, INC. | $98.19 | 5 |
| Novo Nordisk AS | $89.63 | 5 |
| Acerta Pharma LLC | $40.08 | 2 |
| GlaxoSmithKline, LLC. | $17.69 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.68 | 1 |
| Phathom Pharmaceuticals, Inc. | $17.12 | 1 |
| Lilly USA, LLC | $15.97 | 1 |
| Exact Sciences Corporation | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.46 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157555 | CMS |
| ABBVIE INC. | $17.79 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157557 | CMS |
| ABBVIE INC. | $15.93 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157559 | CMS |
| ABBVIE INC. | $21.57 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157561 | CMS |
| ABBVIE INC. | $11.32 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157563 | CMS |
| ABBVIE INC. | $10.61 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157565 | CMS |
| ABBVIE INC. | $15.93 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157567 | CMS |
| ABBVIE INC. | $17.39 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157569 | CMS |
| ABBVIE INC. | $15.10 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157571 | CMS |
| ABBVIE INC. | $0.45 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157573 | CMS |
| ABBVIE INC. | $0.77 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157575 | CMS |
| ABBVIE INC. | $13.27 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157577 | CMS |
| ABBVIE INC. | $0.43 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157579 | CMS |
| ABBVIE INC. | $16.93 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157581 | CMS |
| ABBVIE INC. | $12.88 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157583 | CMS |
| ABBVIE INC. | $22.13 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157585 | CMS |
| ABBVIE INC. | $17.55 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108157587 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.03 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104470096 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.05 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104507368 | CMS |
| Dexcom, Inc. | $17.11 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353148 | CMS |
| Dexcom, Inc. | $18.94 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353150 | CMS |
| Dexcom, Inc. | $22.81 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353152 | CMS |
| Dexcom, Inc. | $20.12 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353154 | CMS |
| Dexcom, Inc. | $19.21 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353156 | CMS |
| Exact Sciences Corporation | $14.12 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114879992 | CMS |
| GlaxoSmithKline, LLC. | $17.69 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116269631 | CMS |
| Lilly USA, LLC | $15.97 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135598689 | CMS |
| Novo Nordisk Inc | $13.09 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100572850 | CMS |
| Novo Nordisk Inc | $21.52 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100379977 | CMS |
| Novo Nordisk Inc | $13.86 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100511701 | CMS |
| Novo Nordisk Inc | $23.95 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100606296 | CMS |
| Novo Nordisk Inc | $17.21 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100478886 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.12 | 09/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151203639 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.68 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153559523 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.